Pandemic Influenza Vaccine Patent Application EP2026029847A1

ChangeBridge: EPO Bulletin - Biotech (C12N)

Published March 18th, 2026

Detected March 24th, 2026

Summary

The European Patent Office has published patent application EP2026029847A1 concerning methods and compositions for a pandemic influenza vaccine. The publication date is March 18, 2026, and the inventors have not yet been designated.

View original document View source feed page

What changed

This document is a publication of a European patent application (EP2026029847A1) related to methods and compositions for a pandemic influenza vaccine. The publication date is March 18, 2026. The application is classified under various International Patent Classifications (IPC) related to biotechnology and vaccines. The designated states include a broad range of European countries.

As this is a patent application publication, there are no immediate compliance obligations for regulated entities. However, it signifies potential future developments in vaccine technology and intellectual property within the pharmaceutical sector. Companies involved in vaccine research and development should monitor this and similar patent filings for competitive intelligence and potential licensing opportunities.

Source document (simplified)

← EPO Patent Bulletin

METHODS AND COMPOSITIONS FOR PANDEMIC INFLUENZA VACCINE

Publication EP2026029847A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

C12N 15/86 20060101AFI20260208BHEP A61K 31/7088 20060101ALI20260208BHEP A61K 31/7105 20060101ALI20260208BHEP A61K 35/76 20150101ALI20260208BHEP A61K 39/12 20060101ALI20260208BHEP A61K 39/145 20060101ALI20260208BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →